Quantitative and functional characterisation of extracellular vesicles after passive loading with hydrophobic or cholesterol-tagged small molecules.


Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
09 2023
Historique:
received: 27 03 2023
revised: 03 07 2023
accepted: 07 08 2023
medline: 11 9 2023
pubmed: 12 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Extracellular vesicles (EVs) are nanosized intercellular messengers that bear enormous application potential as biological drug delivery vehicles. Much progress has been made for loading or decorating EVs with proteins, peptides or RNAs using genetically engineered donor cells, but post-isolation loading with synthetic drugs and using EVs from natural sources remains challenging. In particular, quantitative and unambiguous data assessing whether and how small molecules associate with EVs versus other components in the samples are still lacking. Here we describe the systematic and quantitative characterisation of passive EV loading with small molecules based on hydrophobic interactions - either through direct adsorption of hydrophobic compounds, or by membrane anchoring of hydrophilic ligands via cholesterol tags. As revealed by single vesicle imaging, both ligand types bind to CD63 positive EVs (exosomes), however also non-specifically to other vesicles, particles, and serum proteins. The hydrophobic compounds Curcumin and Terbinafine aggregate on EVs with no apparent saturation up to 10

Identifiants

pubmed: 37567507
pii: S0168-3659(23)00506-0
doi: 10.1016/j.jconrel.2023.08.010
pii:
doi:

Substances chimiques

Curcumin IT942ZTH98
Ligands 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

694-716

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Gwenola Tréton (G)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Claudia Sayer (C)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Melanie Schürz (M)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Maria Jaritsch (M)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Anna Müller (A)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Cristian-Tudor Matea (CT)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Vesna Stanojlovic (V)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Heloisa Melo-Benirschke (H)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Celine Be (C)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Caroline Krembel (C)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Stephane Rodde (S)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Matthias Haffke (M)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Samuel Hintermann (S)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Andreas Marzinzik (A)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Sébastien Ripoche (S)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Constantin Blöchl (C)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Julia Hollerweger (J)

GMP Unit, Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, Salzburg, Austria.

Daniela Auer (D)

GMP Unit, Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, Salzburg, Austria.

Chiara Cabrele (C)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Christian G Huber (CG)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria.

Martin Hintersteiner (M)

EvoBiotiX SA, Via Lungo Lago 86, 6815 Melide, Switzerland.

Trixie Wagner (T)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Andreas Lingel (A)

Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland. Electronic address: andreas.lingel@novartis.com.

Nicole Meisner-Kober (N)

University of Salzburg, Department of Biosciences and Medical Biology, Hellbrunnerstrasse 34, 5020 Salzburg, Austria. Electronic address: nicole.meisner-kober@plus.ac.at.

Articles similaires

Curcumin Spinal Cord Injuries Humans Animals Neural Stem Cells
Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics
Extracellular Vesicles Bacteria Humans
Humans RNA, Circular Extracellular Vesicles Body Fluids Biomarkers

Classifications MeSH